Navigation Links
The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
Date:7/23/2008

first six weeks of therapy and treated as needed. Bleeding with a fatal outcome from any site was reported in 2.4% for Nexavar and 4% in placebo. The incidence of treatment-emergent cardiac ischemia/infarction was 2.7% for Nexavar vs. 1.3% for placebo. Most common adverse events reported with Nexavar in patients with unresectable HCC were diarrhea, fatigue, abdominal pain, weight loss, anorexia, nausea and hand-foot skin reaction. Grade 3/4 adverse events were 45% for Nexavar vs. 32% for placebo. Women of child-bearing potential should be advised to avoid becoming pregnant and advised against breast-feeding. In cases of any severe or persistent side effects, temporary treatment interruption, dose modification or permanent discontinuation should be considered.

For information about Nexavar including U.S. Nexavar prescribing information, visit http://www.nexavar.com or call 1.866.NEXAVAR (1.866.639.2827).

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R) (sorafenib) tablets, a small molecule drug. For more information about Onyx, visit the company's website at: http://www.onyx-pharm.com.

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals unit of Bayer HealthCare LLC, a division of Bayer AG. One of the world's leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the U.S., Bayer HealthCare Pharmaceuticals comprises the following business units: Women's Healthcare, Diagnostic Imaging, Specialized Therapeu
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals; Onyx Pharmaceuticals,Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
2. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
3. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
4. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
5. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
6. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
7. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
8. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
9. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
10. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
11. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015  Vermillion, Inc. (NASDAQ: VRML ), a ... will present at the 27 th Annual ROTH Conference, ... Dana Point, California from March 8 to March ... Valerie Palmieri , will be presenting on Monday, March 9 ... Eric Schoen , the company,s Vice President of Finance and ...
(Date:3/3/2015)... and Markets ( http://www.researchandmarkets.com/research/tbjpmj/blister_packaging ) has announced ... the US 2015-2019" report to their offering. ... to grow at a CAGR of 6.11% over the ... high-visibility packaging that uses pre-formed plastic packs for small ... layer, made either of plastic or aluminum, with cavities ...
(Date:3/3/2015)... Calif. , March 3, 2015  BioPharmX Corporation ... development of novel drug delivery products to address unmet ... that Jim Pekarsky , chief executive officer and ... Annual Roth Capital Partners Conference on Wednesday, March ... Laguna Niguel in Dana ...
Breaking Medicine Technology:Vermillion To Present at 27th Annual ROTH Conference on March 9 2United States Blister Packaging Market 2015-2019 - Growing Demand in Pharmaceuticals Industry with Amcor, Bemis, MeadWestvaco & Sonoco Products Dominating 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 3
... One of the more difficult aspects of planning ... resource and investment allocations that are needed to prepare ... wrestle with allocating the appropriate resources for informing key ... are carried out across different functional areas. ...
... Floridians turned in nearly 5,500 pounds of prescription and ... enforcement offices throughout the state during the Drug Take ... the amount dropped off at 38 sites last year. ... National Association of Drug Diversion Investigators (NADDI) ...
Cached Medicine Technology:Study Uncovers Key Success Factors and Common Failure Points for Launching New Metabolic Products in Today's Competitive Healthcare Market 2NADDI and the C.A.R.E.S. Alliance Co-Sponsor Successful Drug Take Back Day 2
(Date:3/4/2015)... Nitrosigine®, a patented complex of bonded arginine silicate ... is hosting the Nitrosigine Pump Challenge at the America’s ... The Arnold Sports Festival in Columbus, Ohio. The event ... 2015. , Nitrosigine is a patented ingredient of ... status; now affirmed as GRAS.^ It has been clinically ...
(Date:3/4/2015)... The report “Vasculitis – Pipeline Review, H1 ... Vasculitis. Vasculitis is a disease that features tenderness of ... is not known. Vasculitis can affect any body system ... can include fever, weight loss, tiredness, aches, pains, night ... limb. Vasculitis is treatable, but it is not curable. ...
(Date:3/4/2015)... The week of March 2nd - 8th ... Awareness Day being recognized on March 13th, the aim ... risks associated with sleep related illnesses, costing the United ... of America have turned to social media with an ... virally inspire conversation regarding the disease. , The ...
(Date:3/4/2015)... California (PRWEB) March 04, 2015 ... a worrisome public health issue worldwide. The rising prevalence ... economic and social burden in both developed and developing ... is projected to rise to 1.5 billion, equating to ... of these patients are forecast to come from the ...
(Date:3/4/2015)... Bird B Gone, the leader in ... now offers its popular plastic (polycarbonate) bird spike in ... bird deterrent is ready-to-use and comes in ... décor of the building or structure onto which it ... clear, light grey, brown, black and tan—make the spikes ...
Breaking Medicine News(10 mins):Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 2Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 3Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 4Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 4Health News:Plastic Bird Spikes Now Come in 7 Colors to Blend in With Their Surroundings 2
... world-renowned fragile X syndrome researcher, who was the first ... disorder, will be honored by the March of Dimes. ... Timmie Professor of Human Genetics and Charles Howard Candler ... as professor of biochemistry and pediatrics at Emory University ...
... of persons who smoked 20 or more cigarettes per day declined ... smoking 10 or more cigarettes a day, with these declines greater ... a study in the March 16 issue of JAMA . ... in the United States, consumption was typically 1 pack (about 20 ...
... by a new type of self-monitoring blood glucose sensor being ... Clinic in Arizona. More than 23 million people in ... leading cause of death in the United States. It contributes ... lower extremity amputations and other chronic conditions. Many people ...
... University doctor should be studied and copied as a way to ... problem of adding 40 million people to its health care system ... Health Team Model (FHT) could help ease the burden. "What we ... and efficient way of providing health care," says Walter Rosser, professor ...
... technique has demonstrated that it can measure the interactions between ... other biological molecules. These extremely difficult measurements can aid the ... percent of the 7,000 proteins in a human cell reside ... 60 to 70 percent of the signals that control the ...
... 15, 2011Since the first laparoscopic procedure was performed to ... University in St. Louis, this breakthrough minimally invasive technique ... This remarkable achievement is celebrated with a series of ... peer-reviewed journal published by Mary Ann Liebert, Inc. ( ...
Cached Medicine News:Health News:Fragile X researcher honored by March of Dimes 2Health News:Prevalence of heavy smokers in US decreases 2Health News:Prevalence of heavy smokers in US decreases 3Health News:New device holds promise of making blood glucose testing easier for patients with diabetes 2Health News:New device holds promise of making blood glucose testing easier for patients with diabetes 3Health News:New laser technique opens doors for drug discovery 2Health News:20th anniversary of first laparoscopic nephrectomy 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: